We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+20.7%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.39B
AUM Growth
+$176M
Cap. Flow
-$61.1M
Cap. Flow %
-4.41%
Top 10 Hldgs %
49.12%
Holding
37
New
6
Increased
8
Reduced
16
Closed
2

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$46.2M
2
CNC icon
Centene
CNC
+$41.5M
3
LIVN icon
LivaNova
LIVN
+$38.5M
4
HCA icon
HCA Healthcare
HCA
+$25.1M
5
QDEL icon
QuidelOrtho
QDEL
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 51.03%
2 Consumer Discretionary 15.11%
3 Technology 12.77%
4 Communication Services 5.22%
5 Consumer Staples 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$18.1B
$88.2M 6.36%
606,982
+124,045
+26% +$17.1M
ALC icon
2
Alcon
ALC
$33.5B
$80.4M 5.8%
1,422,079
+125,144
+10% +$7.17M
CNC icon
3
Centene
CNC
$30.7B
$77.3M 5.58%
1,229,609
+765,381
+165% +$41.5M
GDDY icon
4
GoDaddy
GDDY
$10.5B
$74.5M 5.38%
1,097,145
-43,600
-4% -$2.88M
HCA icon
5
HCA Healthcare
HCA
$86.9B
$72.8M 5.25%
492,256
+186,945
+61% +$25.1M
CZR icon
6
Caesars Entertainment
CZR
$6.06B
$70.2M 5.06%
1,176,393
-116,604
-9% -$5.77M
POST icon
7
Post Holdings
POST
$4.15B
$62.8M 4.53%
880,194
-34,991
-4% -$2.39M
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$27.1B
$53.9M 3.89%
467,918
+116,157
+33% +$11.6M
GDS icon
9
GDS Holdings
GDS
$6.5B
$51.1M 3.68%
989,787
-184,636
-16% -$8.27M
MS icon
10
Morgan Stanley
MS
$332B
$49.8M 3.59%
973,461
-291,027
-23% -$13.8M
ATRA icon
11
Atara Biotherapeutics
ATRA
$74.4M
$48.3M 3.48%
117,315
+10,874
+10% +$3.75M
CHTR icon
12
Charter Communications
CHTR
$17.4B
$48.2M 3.48%
99,459
-48,160
-33% -$22.2M
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
$46.3M 3.34%
887,459
+141,792
+19% +$6.49M
HUM icon
14
Humana
HUM
$44.1B
$45.6M 3.29%
124,387
-127,913
-51% -$40.6M
LKQ icon
15
LKQ Corp
LKQ
$5.7B
$45.6M 3.29%
1,276,708
-61,100
-5% -$2.07M
DRNA
16
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$43.7M 3.15%
1,981,633
-676,563
-25% -$13.6M
NTRA icon
17
Natera
NTRA
$38.3B
$42.2M 3.04%
+1,252,746
New +$46.2M
HRTX icon
18
Heron Therapeutics
HRTX
$95.4M
$40.5M 2.92%
1,721,816
-704,798
-29% -$15.6M
LIVN icon
19
LivaNova
LIVN
$4.43B
$38.3M 2.76%
+507,621
New +$38.5M
MGM icon
20
MGM Resorts International
MGM
$11.4B
$38M 2.74%
1,143,396
-300,147
-21% -$9.14M
VRSN icon
21
VeriSign
VRSN
$26.1B
$33.3M 2.4%
172,604
ETSY icon
22
Etsy
ETSY
$7.87B
$28.4M 2.05%
641,994
SHAK icon
23
Shake Shack
SHAK
$2.54B
$27.2M 1.96%
456,828
+93,986
+26% +$6.75M
MDCO
24
DELISTED
Medicines Co
MDCO
$25.9M 1.87%
305,002
-1,102,294
-78% -$73.5M
QDEL icon
25
QuidelOrtho
QDEL
$1.13B
$21.5M 1.55%
+286,697
New +$18.5M

Similar funds

Bridger Management's Q4 2019 Portfolio in Review

As of Q4 2019, Bridger Management held 37 positions worth $1.39B, up 15% from $1.21B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bridger Management withdrew a net $61.1M in Q4 2019, closing 2 positions and reducing 16 holdings. Its most notable exit was Wright Medical Group Inc, an estimated $46.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Bridger Management opened a new position in Natera worth $42.2M.

  • Bridger Management's largest Q4 2019 buy was Natera: 1,252,746 shares worth $42.2M.
  • Bridger Management added most to Centene in Q4 2019, an estimated $41.5M increase.
  • Bridger Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $73.5M.
  • Bridger Management fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $46.5M.
  • Bridger Management's ten largest holdings make up 49% of its $1.39B portfolio in Q4 2019.
  • Bridger Management opened 6 new positions and closed 2 in Q4 2019.
  • Bridger Management's portfolio value rose 15% quarter-over-quarter to $1.39B.

Based on Bridger Management's 13F filing for Q4 2019, filed 14 Feb 2020.